Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank27
Year-over-Year Change
Year-over-year book value per share growth
Latest
-49.42%
↓ 881% vs avg
Percentile
P27
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-5.04%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -49.42% |
| Q2 2025 | 869.55% |
| Q1 2025 | -436.85% |
| Q4 2024 | 100.39% |
| Q3 2024 | -432.41% |
| Q2 2024 | -149.88% |
| Q1 2024 | -252.80% |
| Q4 2023 | -37.31% |
| Q3 2023 | -9.69% |
| Q2 2023 | -49.35% |
| Q1 2023 | -47.67% |
| Q4 2022 | -8.21% |
| Q3 2022 | -40.39% |
| Q2 2022 | -22.15% |
| Q1 2022 | -34.13% |
| Q4 2021 | 89.94% |
| Q3 2021 | -68.87% |
| Q2 2021 | 621.14% |
| Q1 2021 | -157.73% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |